Results

Total Results: 188 records

Showing results for "hepatitis c".
Users also searched for: hepatitis c

61. Cell-Free-Dna-Final-App-C (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - Table C-1. KQ 3,4, 5 Char. … Table C-4. KQ 5-Outcomes Table C-4. … Table C-5. ROB KQ 3 Table C-5. … Table C-6. ROB KQ 4, 5 Table C-6. … Table C-8. TACIT KQ 3,4, 5 Table C-8.

62. women-hiv-protocol-160301 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
    March 01, 2016 - Examples of co-occurring diseases of interest include cancer, infections (including hepatitis C, human … Clark RA, Cohn SE, Jarek C, et al. … Imai K, Sutton MY, Mdodo R, Del Rio C. … Grov C, Golub SA, Parsons JT, Brennan M, Karpiak SE. … Ferron P, Young S, Boulanger C, Rodriguez A, Moreno J.

63. Executive Summary_Comparative Effectiveness Review No. 254: Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-executive-summary.pdf
    December 01, 2022 - c. How does provider-to-provider telehealth affect outcomes for private and public payers? … o Hepatitis C viral response and serious adverse events rates at “spoke” site with ECHO participation … Zahnd WE, Rodriguez C, Jenkins WD. … .22(23)-EHC023-1 December 2022 8 Full Report Totten A, Womack DM, McDonagh MS, Davis-O’Reilly C, … c. How does provider-to-provider telehealth affect outcomes for private and public payers?

64. Disposition of comments_Comparative Effectiveness Review No. 244: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
    May 25, 2021 - (Table C.5). … TEP #4 Methods Table C.5 in the appendix C could use a legend explaining the rating system. … for hepatitis A vaccines and hepatitis B vaccines. … Page 30: Wasn’t there any clinical trial data for the safety of the combined hepatitis A-hepatitis … from that of hepatitis B vaccines.

65. Pharmacotherapy for Adults with Alcohol-Use Disorders in Outpatient Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
    September 01, 2017 - those who are non-obese, smokers, HIV-infected, cocaine dependent; those with anxiety, depression, Hepatitis … those who are non-obese, smokers, HIV-infected, cocaine dependent; those with anxiety, depression, Hepatitis … (n=30) (NOTE: abstract differs from results, Figure 1, and discussion) An RCT of veterans with Hepatitis … The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized … Brewer C, Streel E, Skinner M.

66. Cell-Free-Dna-Appendix-C-Prepub-Final (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
    January 01, 2025 - Table C-1. KQ 3,4, 5 Char. … Table C-4. KQ 5-Outcomes Table C-4. … Table C-5. ROB KQ 3 Table C-5. … Table C-6. ROB KQ 4, 5 Table C-6. … Table C-8. TACIT KQ 3,4, 5 Table C-8.

67. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - TEP #4 Executive Summary— Results, Table D (and Table 32), Page 21, lines 34 Also for Hepatitis … for hepatitis A”. … NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J, Lewis N, Deosaransingh K, Sy L, Ackerson B, Cheetham … Macartney KK, Chiu C, Georgousakis M, Brotherton JM. … Baxter R, Bakshi N, Fireman B, Lewis E, Ray P, Vellozzi C, Klein NP.

68. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
    March 09, 2010 - Polygam S/D Privigen 10% Vivaglobin Interaction with activating Fc receptors; biologic No Hepatitis … Specifically, we will examine mortality, malignancy, serious infection, hepatitis, bone marrow suppression … C. … Manners PJ, Bowers C. Worldwide prevalence of juvenile arthritis – why does it vary so much? … Wang C, Chung M, Balk E, et al. Effects of Omega-3 Fatty Acids on Cardiovascular Disease.

69. PEPTIC ULCER #11 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - HHSA290-2010-00006-C Prepared by: ECRI Institute 5200 Butler Pike Plymouth Meeting, PA 19462 … HHSA290-2010-00006-C). … HHSA290-2010-00006-C.) Rockville, MD: Agency for Healthcare Research and Quality.

70. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - Suggested citation: Cuevas C, Koman C, Lynch M, Stewart R, Wilkinson B, Robertson DC, Schoelles K. … C). … Interferon-free Oral Therapies for Chronic Hepatitis C Infection At least 3.2 million Americans are … living with chronic hepatitis C virus (HCV) infection (some estimates are as high as 5.7 million). … Oral Interferon-free Treatment Regmens for Hepatitis C Virus Viekira Pak is an oral combination

71. Liver Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/liver-diseases

72. rheumatoid-arthritis-medicine-update-protocol-170515 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
    May 15, 2017 - challenge for clinicians is treating RA in patients with significant coexisting conditions such as hepatitis … C, congestive heart failure, diabetes, and cancer. … C. … early RA can be used effectively or safely for patients with significant coexisting ailments such as hepatitis … C, congestive heart failure, cancer, diabetes, and others.

73. Association Between Outcomes and Dental Services in People at Risk of Post-Transplant Complications: A Rapid Response Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
    May 01, 2025 - C. … C.; Mendonça, E. F.; Batista, A. C. … C. N.; Freire, G. C. B.; de Araújo Silva, D. N.; de Lima, K. C.; da Silveira, É. J. … Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis … B Virus, and Hepatitis C Virus Infection — U.S.

74. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - o High-density lipoprotein cholesterol (HDL-C) o Triglycerides o Lipoprotein a [LP(a)] o Non–HDL-C … (aspartate aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis … C. … HLD-C, non–HDL-C, triglycerides), international normalised ratio, incidence of metabolic syndrome, … Maraldi C, Lattanzio F, Onder G, et al.

75. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
    May 01, 2006 - Risk of hepatitis B infection is estimated to be 1 in 220,000 per unit of blood transfused. … For each of the following pairs of dosing strategies,d one large trial 4 c To test survival, a trial … Piper M, Bohlius J, Weingart O, Trelle S, Engert A, Skoetz N, Schwarzer G, Wilson J, Brunskill S, Hyde C, … Bonnell C, Ziegler KM, Aronson N.

76. Organisation (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
    June 16, 2008 - 1 Appendix C. … Citation PMID Desjardins L, Levy C, D'Hermies F, et al. … British Journal of Ophthalmology 2001;85(11):1305-8. 11673294 Lumbroso L, Levy C, Plancher C, et … Perret C, et al. … Focused radiation hepatitis after Bragg-peak proton therapy for hepatocellular carcinoma: CT findings

77. Grades-Predictive-Values White-Paper-2015 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
    January 01, 2015 - c. … Charoenkwan K, Kietpeerakool C. … Hepatitis A immunisation in persons not previously exposed to hepatitis A. … Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. … Main C, Knight B, Moxham T, et al.

78. Kidney-Disease-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
    October 01, 2012 - ...................................................................................... 26 Appendix C. … Appendix C shows the questionnaire matrix that was sent to the experts. 2.4 Check for qualitative … Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in … Goraya N, Simoni J, Jo C, et al. … Evidence Table Appendix C. Questionnaire Matrix

79. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - ...................................................................................... 19 Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux T, et al. Scleritis: a paradoxical effect of etanercept? … Sandborg C, Mellins ED. A new era in the treatment of systemic juvenile idiopathic arthritis. … C-reactive protein and ferritin normalized within this interval in >80%. … AE’s included bacterial infection in 2 patients and hepatitis in 1 Key Question 2: In children with

80. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - ...................................................................................... 19 Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux T, et al. Scleritis: a paradoxical effect of etanercept? … Sandborg C, Mellins ED. A new era in the treatment of systemic juvenile idiopathic arthritis. … C-reactive protein and ferritin normalized within this interval in >80%. … AE’s included bacterial infection in 2 patients and hepatitis in 1 Key Question 2: In children with